Ottawa Regional Cancer Clinic, University of Ottawa


Update Clinical Trials for my Centre
Ottawa Regional Cancer Clinic,
University of Ottawa
Open Trial Description

NCIC CTG
OV 16

 

A phase III study of cisplatin plus topotecan followed by paclitaxel plus carboplatin versus paclitaxel plus carboplatin as first-line chemotherapy in women with newly diagnosed advanced epithelial ovarian cancer.

Contact: Kelly-Anne Baines

Local
OTT 02-05

 

A pilot, phase 2, single center, non-comparative, open-label study of Aromasin (Exemestane) in patients with recurrent or refractory stage 2-4 epithelial ovarian cancer.

Contact: Kelly-Anne Baines

PMHC
PHL-019

 

A phase II study of UNC-01 in combination with topotecan in patients with advanced ovarian cancer.

Contact: Kelly-Anne Baines

GSK
104864-557

A phase II trial of topotecan and cisplatin in patients with metastatic or recurrent squamous cell carcinoma of the cervix.

Contact: Kelly-Anne Baines